Seeing is investing: The power of visuals at every stage of ...
Whether your biotech start-up is in its infancy or on the verge of a major acquisition, how you communicate your work – through clear messaging and impactful visuals – can play a pivotal ro
Patient organisations 'too influenced by corporate funders'
Researchers have called for action to safeguard the independence of patient advocacy organisations as they increasingly rely on pharma funding.
London-listed Poolbeg discussing Hookipa merger
The UK's Poolbeg Pharma has disclosed that it is in talks over a possible takeover by Hookipa, an Austrian biotech that is listed on the Nasdaq.
A five-step approach for optimising established brands' port...
Established brands represent the majority of portfolios across pharma’s global affiliates that are often neglected, with revenue and profit growth untapped.
CARsgen gets a win for CAR-T in solid tumours
CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satri-cel has shown efficacy in gastric cancer, setting up a filing in China.
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
hubXchange returns with its latest series of roundtables!
hubXchange invites you to participate in its highly-anticipated San Diego Series 2025, a series of focused, high-level roundtable events designed to address key challenges and innovations across th
Advance Best-In-Class Treatment Across CNS, Emergency Use Tr...
With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics.
7th Treg-Directed Therapies Summit
Unravelling Treg Biology, Pioneering Best-in-Class Approaches & Demonstrating Clinical Efficacy to Advance Validated Therapeutic Options in Autoimmunity, Inflammation & Beyond
Welcome to the Bacteriophage Therapy Summit!
Combating Antibiotic Resistance with Effective & Sustainable Phage-Based Therapies
Biotech Showcase marking 17 years of innovation and opportun...
Biotech Showcase is a cornerstone of the life science industry, with a 17-year history of connecting private and micro- to mid-cap biotech companies with top-tier investors and biopharmaceu